ALKS vs CL
Alkermes Plc (ALKS) versus Colgate-Palmolive Company (CL) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Not investment advice. Open the ALKS and CL stock pages for the full models.
Not investment advice.